Pharmacodynamic markers and clinical results from the Phase II Study of the SMAC-Mimetic Birinapant in Women with Relapsed Platinum-Resistant or Refractory Epithelial Ovarian Cancer
Saved in:
Published in | Cancer Vol. 122; no. 4; pp. 588 - 597 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
13.11.2015
|
Online Access | Get full text |
Cover
Loading…
Bibliography: | Current address: Division of Medical Oncology, The Ohio State University, Columbus, OH |
---|---|
ISSN: | 0008-543X 1097-0142 |
DOI: | 10.1002/cncr.29783 |